Hepatitis C, Chronic: all 1,090 studies
Page 11 of 11. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.CompletedNCT00377182Phase 2
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCCCompletedNCT00375661Phase 4
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceStatus unknownNCT00370617Phase 4
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C InfectionCompletedNCT00352235Phase 1/2
- Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol TherapyCompletedNCT00351871Phase 4
- Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00351403Phase 4
- Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CCompletedNCT00343525Phase 1
- Continuing Treatment With Pegasys and CopegusStatus unknownNCT00336518Phase 3
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
- Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis CCompletedNCT00322179
- Chronic Hepatitis C Non-Responder Study With AdoMet and BetaineCompletedNCT00310336Phase 2/3
- Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CTerminatedNCT00305383Phase 2
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral MedicationTerminatedNCT00296972Phase 3
- Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALTStatus unknownNCT00294489
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00292084Phase 2
- Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing RegimenCompletedNCT00286871Phase 1
- Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)TerminatedNCT00279565Phase 4
- Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype ITerminatedNCT00277758Phase 1
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis CCompletedNCT00265642Phase 3
- Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis CCompletedNCT00262379Phase 3
- Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or RelapsersWithdrawnNCT00255359Phase 1
- A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedNCT00249860Phase 3
- Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus InfectionCompletedNCT00248339Phase 3
- Trial of Pegasys® in Patients With Chronic Hepatitis CCompletedNCT00245414Phase 4
- Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)CompletedNCT00237484Phase 3
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedNCT00230958Phase 3
- Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and RibavirinCompletedNCT00230854Phase 1
- Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis CCompletedNCT00227435Phase 1/2
- Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis CCompletedNCT00227149
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected PatientsCompletedNCT00221650Phase 2
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected PatientsCompletedNCT00221624Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00217139Phase 2
- Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis CCompletedNCT00216775
- PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonCompletedNCT00215891Phase 3
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNCT00215865Phase 3
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon TherapyStatus unknownNCT00215839Phase 3
- Hepatitis C Treatment of InmatesTerminatedNCT00209898Phase 4
- Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis CTerminatedNCT00209755Not applicable
- Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAMCompletedNCT00199719Phase 2
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
- Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsCompletedNCT00196586Phase 2
- Pioglitazone in Hepatitis CCompletedNCT00189163Phase 4
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral TherapyStatus unknownNCT00188240Not applicable
- Natural History of Hepatitis C in Patients With Normal Liver TestsCompletedNCT00187473
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus InfectionStatus unknownNCT00164073
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00162734Phase 3
- Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)CompletedNCT00158496Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00157534Phase 2
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 EradicationCompletedNCT00152581Phase 4
- Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNCT00148863Phase 2
- Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe FibrosisCompletedNCT00148837Phase 2
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis CCompletedNCT00144469Phase 3
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)Status unknownNCT00127777Phase 4
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C InfectionCompletedNCT00124215Phase 1
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2
- Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
- Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis CTerminatedNCT00119119Phase 3
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedNCT00118768Phase 2
- A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
- SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
- A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis CCompletedNCT00097435Phase 2
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNCT00093093Phase 3
- Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis CCompletedNCT00088504Phase 2
- A Caspase Inhibitor in Chronic Hepatitis C (HCV) PatientsCompletedNCT00088140Phase 2
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00086541Phase 3
- CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
- Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two DrugsCompletedNCT00062816Phase 1/2
- IdB 1016 Treatment for Hepatitis C DiseaseCompletedNCT00055445Phase 1/2
- Study of FK788 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00047814Phase 2
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00040027Phase 3
- Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00039962Phase 3
- ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus InfectionsCompletedNCT00035945Phase 2
- Evaluating Silymarin for Chronic Hepatitis CCompletedNCT00030030Phase 2
- Gamma Interferon Therapy for Chronic Hepatitis CCompletedNCT00028275Phase 2
- Long-Term Therapy With Ribavirin for Chronic Hepatitis CCompletedNCT00001854Phase 4
- Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3